z-logo
open-access-imgOpen Access
Edible Safety Assessment of Genetically Modified Rice T1C-1 for Sprague Dawley Rats through Horizontal Gene Transfer, Allergenicity and Intestinal Microbiota
Author(s) -
Kai Zhao,
Fangfang Ren,
Fangting Han,
Qiwen Liu,
Guogan Wu,
Yan Xu,
Jian Zhang,
Ximei Wu,
Jinbin Wang,
Peng Li,
Wei Shi,
Zhu Hong,
LV Jian-jun,
Xianda Zhao,
Xueming Tang
Publication year - 2016
Publication title -
plos one
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.99
H-Index - 332
ISSN - 1932-6203
DOI - 10.1371/journal.pone.0163352
Subject(s) - bacillus thuringiensis , genetically modified rice , biology , transgene , genetically modified organism , genetically modified crops , toxicity , gut flora , microbiology and biotechnology , oryza , gene , food science , bacteria , oryza sativa , biochemistry , genetics , medicine
In this study, assessment of the safety of transgenic rice T1C-1 expressing Cry1C was carried out by: (1) studying horizontal gene transfer (HGT) in Sprague Dawley rats fed transgenic rice for 90 d; (2) examining the effect of Cry1C protein in vitro on digestibility and allergenicity; and (3) studying the changes of intestinal microbiota in rats fed with transgenic rice T1C-1 in acute and subchronic toxicity tests. Sprague Dawley rats were fed a diet containing either 60% GM Bacillus thuringiensis (Bt) rice T1C-1 expressing Cry1C protein, the parental rice Minghui 63, or a basic diet for 90 d. The GM Bt rice T1C-1 showed no evidence of HGT between rats and transgenic rice. Sequence searching of the Cry1C protein showed no homology with known allergens or toxins. Cry1C protein was rapidly degraded in vitro with simulated gastric and intestinal fluids. The expressed Cry1C protein did not induce high levels of specific IgG and IgE antibodies in rats. The intestinal microbiota of rats fed T1C-1 was also analyzed in acute and subchronic toxicity tests by DGGE. Cluster analysis of DGGE profiles revealed significant individual differences in the rats' intestinal microbiota.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here